HOOKIPA Pharma Q4 EPS $(0.22) Misses $(0.19) Estimate, Sales $7.41M Beat $4.55M Estimate, Cash Balance of $117.5M

Author: Benzinga Newsdesk | March 22, 2024 07:03am
HOOKIPA Pharma (NASDAQ:HOOK) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 29.41 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $7.41 million which beat the analyst consensus estimate of $4.55 million by 62.79 percent. This is a 5.38 percent decrease over sales of $7.83 million the same period last year.

Posted In: HOOK